Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Sáez-Llorens, Xavier, Beltran-Rodriguez, Johnny, Novoa Pizarro, Jose M., Mensi, Ilhem, Keshavan, Pavitra, Toneatto, Daniela
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989907/
https://ncbi.nlm.nih.gov/pubmed/29601256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1457595
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires